National Plastic Technologies Ltd
BSE:531287
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
National Plastic Technologies Ltd
BSE:531287
|
IN |
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
JP |
|
Ulker Biskuvi Sanayi AS
IST:ULKER.E
|
TR |
|
Mahamaya Steel Industries Ltd
NSE:MAHASTEEL
|
IN |
|
A
|
Alinco Inc
TSE:5933
|
JP |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
SA |
Balance Sheet
Balance Sheet Decomposition
National Plastic Technologies Ltd
National Plastic Technologies Ltd
Balance Sheet
National Plastic Technologies Ltd
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
1
|
1
|
1
|
11
|
9
|
5
|
7
|
6
|
3
|
9
|
8
|
4
|
9
|
5
|
5
|
6
|
|
| Cash |
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
7
|
6
|
3
|
3
|
6
|
1
|
2
|
2
|
2
|
2
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
11
|
9
|
5
|
1
|
0
|
0
|
6
|
2
|
3
|
8
|
3
|
3
|
3
|
|
| Short-Term Investments |
8
|
5
|
8
|
9
|
9
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
137
|
153
|
177
|
181
|
191
|
146
|
187
|
221
|
265
|
232
|
190
|
156
|
167
|
157
|
196
|
270
|
387
|
498
|
503
|
|
| Accounts Receivables |
107
|
122
|
129
|
138
|
152
|
136
|
142
|
170
|
216
|
221
|
185
|
142
|
150
|
130
|
176
|
259
|
376
|
487
|
500
|
|
| Other Receivables |
30
|
32
|
48
|
43
|
39
|
10
|
45
|
51
|
49
|
11
|
5
|
14
|
17
|
27
|
20
|
11
|
11
|
11
|
3
|
|
| Inventory |
67
|
88
|
85
|
81
|
76
|
69
|
80
|
100
|
96
|
90
|
93
|
104
|
128
|
170
|
260
|
323
|
278
|
309
|
317
|
|
| Other Current Assets |
4
|
5
|
5
|
17
|
15
|
40
|
0
|
0
|
0
|
33
|
39
|
81
|
47
|
46
|
74
|
41
|
55
|
55
|
69
|
|
| Total Current Assets |
216
|
253
|
278
|
287
|
291
|
265
|
278
|
330
|
366
|
362
|
327
|
344
|
352
|
382
|
535
|
644
|
724
|
867
|
894
|
|
| PP&E Net |
198
|
216
|
227
|
227
|
256
|
245
|
238
|
228
|
220
|
210
|
210
|
242
|
351
|
370
|
482
|
511
|
633
|
739
|
752
|
|
| PP&E Gross |
198
|
216
|
227
|
227
|
256
|
245
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
145
|
156
|
168
|
172
|
183
|
196
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
18
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
4
|
9
|
10
|
|
| Total Assets |
432
N/A
|
468
+8%
|
505
+8%
|
513
+2%
|
550
+7%
|
514
-7%
|
519
+1%
|
561
+8%
|
589
+5%
|
578
-2%
|
544
-6%
|
592
+9%
|
707
+19%
|
756
+7%
|
1 021
+35%
|
1 159
+14%
|
1 363
+18%
|
1 617
+19%
|
1 659
+3%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
80
|
145
|
103
|
108
|
123
|
93
|
46
|
87
|
111
|
88
|
74
|
55
|
57
|
84
|
111
|
124
|
215
|
315
|
253
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
122
|
140
|
135
|
122
|
144
|
129
|
167
|
236
|
220
|
283
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
12
|
27
|
41
|
56
|
414
|
406
|
481
|
507
|
|
| Other Current Liabilities |
60
|
19
|
73
|
63
|
55
|
6
|
60
|
60
|
46
|
16
|
14
|
26
|
21
|
19
|
40
|
44
|
72
|
80
|
98
|
|
| Total Current Liabilities |
140
|
164
|
176
|
172
|
179
|
223
|
247
|
282
|
280
|
257
|
225
|
260
|
341
|
364
|
490
|
582
|
693
|
875
|
858
|
|
| Long-Term Debt |
225
|
234
|
234
|
214
|
221
|
32
|
15
|
7
|
62
|
60
|
47
|
56
|
98
|
93
|
157
|
164
|
108
|
108
|
93
|
|
| Deferred Income Tax |
6
|
10
|
17
|
32
|
34
|
34
|
35
|
36
|
35
|
36
|
33
|
35
|
34
|
40
|
44
|
51
|
55
|
65
|
70
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
86
|
71
|
71
|
33
|
33
|
40
|
35
|
12
|
13
|
72
|
68
|
153
|
138
|
124
|
|
| Total Liabilities |
371
N/A
|
407
+10%
|
427
+5%
|
418
-2%
|
433
+4%
|
375
-13%
|
368
-2%
|
396
+8%
|
410
+4%
|
386
-6%
|
346
-10%
|
387
+12%
|
485
+25%
|
511
+5%
|
763
+49%
|
865
+13%
|
1 010
+17%
|
1 186
+17%
|
1 145
-3%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
57
|
57
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
61
|
|
| Retained Earnings |
1
|
1
|
13
|
30
|
51
|
78
|
91
|
104
|
118
|
131
|
137
|
145
|
162
|
184
|
197
|
233
|
293
|
370
|
453
|
|
| Additional Paid In Capital |
4
|
4
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
61
N/A
|
61
+0%
|
78
+29%
|
96
+22%
|
117
+22%
|
138
+18%
|
151
+9%
|
164
+9%
|
178
+8%
|
192
+7%
|
198
+4%
|
205
+4%
|
223
+8%
|
245
+10%
|
258
+5%
|
294
+14%
|
354
+20%
|
431
+22%
|
514
+19%
|
|
| Total Liabilities & Equity |
432
N/A
|
468
+8%
|
505
+8%
|
513
+2%
|
550
+7%
|
514
-7%
|
519
+1%
|
561
+8%
|
589
+5%
|
578
-2%
|
544
-6%
|
592
+9%
|
707
+19%
|
756
+7%
|
1 021
+35%
|
1 159
+14%
|
1 363
+18%
|
1 617
+19%
|
1 659
+3%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|